Skip to main content
Premium Trial:

Request an Annual Quote

Ann Hagan, Stephen Kingsmore, Susan Baxter, Axel Ullrich, Sylvia Streit, Jens Ruhe, Stefan Hart, Katja Specht, Wolfgang Fries, Robyn Owens, Andy O Guin, Ellen Jones


The US National Institute of General Medical Sciences, of the National Institutes of Health has named Ann Hagan as associate director for extramural activities, the institute said last week. Hagan has been at NIGMS since 2000 as associate director for extramural activities, and has served as acting associate director since November 2003. Between 1989 and 2000, she was at the National Institute of Diabetes and Digestive and Kidney Diseases, and served as chief of the review branch. She received BS and MS degrees in biology education and a PhD in physiology, all from the University of Illinois at Urbana-Champaign.

The National Center for Genome Resources has named Stephen Kingsmore as president and Susan Baxter as chief operating officer.

Kingsmore comes to NCGR from Molecular Staging, where he was COO, and CuraGen, where he was vice president of research. He graduated in medicine from the Queen’s University of Belfast, Northern Ireland, and completed his internship and residency in internal medicine, and a fellowship in rheumatology, at Duke University Medical Center.

Baxter comes to NCGR from Cengent Therapeutics (formerly GeneFormatics), where she was vice president of research and genome analysis. She was previously a tenured researcher at the New York State Department of Health’s Wadsworth Center. Baxter received her MS and PhD degrees in chemistry from Northwestern University, and was an NIH postdoctoral fellow at the Institute of Molecular Biology at the University of Oregon.

Axel Ullrich, the director of the department of molecular biology at the Max Planck Institute of Biochemistry in Martinsried, Germany, will lead the Singapore Onco Genome Laboratory beginning in June.

Ullrich is an expert in the field of signal transduction and the development of gene technology-based therapies. He co-founded Sugen, a company that develops small molecule drugs to target signal transduction pathways, in 1991. Sugen was acquired by Pharmacia Upjohn in 1999. He subsequently founded Axxima Pharmaceuticals in 1998, and U3 Pharma in 2002.

He will be joined by four postdoctoral researchers from Max Plank, including Sylvia Streit, Jens Ruhe, Stefan Hart, and Katja Specht, as well as researchers from the Genome Institute of Singapore and Singapore’s Institute of Molecular and Cell Biology.

The Onco Genome Laboratory is a joint research program between the Max Planck Society and the Agency for Science, Technology and Research, and is located in Singapore’s Biopolis.

Qiagen has appointed Wolfgang Fries as vice president of global human resources. He will work from Qiagen’s headquarters in Hilden, The Netherlands, and will be a member of the company’s executive committee.

Before joining Qiagen, Fries served as vice president human resources at GDX Automotive, a subsidiary of GenCorp in Farmington Hills, Mich.

GenoMed has named Robyn Owens as CFO; Andy O’Guin as chief technical officer; and Ellen Jones as vice president for marketing, the St. Louis, Mo.-based company said this week.

Filed under

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.